What is the current Price Target for the Abivax SA stock?

The average Abivax SA target price is €30.15. This is 459.34% higher than the current stock price. The highest price target is 827.64%, the lowest is 106.13%. 12 Analysts have issued a price target Abivax SA 2026 .

How high will the Abivax SA stock rise?

No reliable answer can be given as to how high the Abivax SA stock will rise. The performance of stocks, including the Abivax SA stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Abivax SA stock today?

The performance of Abivax SA stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Abivax SA stock fall?

The decline in Abivax SA stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Abivax SA Forecast, price target & analysts

€5.39

0.92% today

Paris, Apr 03, 05:35 pm CET

ISIN

FR0012333284

Symbol

ABVX

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Abivax SA Target price 2025 - Analyst rating & recommendation

Abivax SA Classifications & Recommendation:

Buy

92%

Hold

Abivax SA Price Target

Target Price	€30.15
Price	€5.39
Potential	459.34% register free of charge
Number of Estimates	12

	12 Analysts have issued a price target Abivax SA 2026 . The average Abivax SA target price is €30.15. This is 459.34% register free of charge higher than the current stock price. The highest price target is €50.00 827.64% register free of charge , the lowest is €11.11 106.13% register free of charge .
	A rating was issued by 12 analysts: 11 Analysts recommend Abivax SA to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Abivax SA stock has an average upside potential 2026 of 459.34% register free of charge . Most analysts recommend the Abivax SA stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share €	-2.80	-2.92
	18.37%	4.29%
P/E		negative
EV/Sales		41.72

4 Analysts have issued a Abivax SA forecast for earnings per share. The average Abivax SA EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	€-2.80	18.37%
2025	€-2.92 4.29% Unlock
2026	€-2.85 2.40% Unlock
2027	€-2.51 11.93% Unlock
2028	€-1.37 45.42% Unlock
2029	€0.48 135.04% Unlock

Current	-1.95	55.78%
2025	-1.86 4.62% Unlock
2026	-1.91 2.69% Unlock
2027	-2.17 13.61% Unlock
2028	-3.99 83.87% Unlock
2029	11.45 386.97% Unlock

Abivax SA...

Current Abivax SA Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
BRYAN GARNIER	Locked ➜ Locked	Locked	Nov 19 2024
LIFESCI CAPITAL	Locked ➜ Locked	Locked	Oct 07 2024
BTIG	Locked ➜ Locked	Locked	Oct 02 2024
ODDO BHF	Locked ➜ Locked	Locked	Sep 09 2024

Analyst Rating	Date
Locked BRYAN GARNIER: Locked ➜ Locked	Nov 19 2024
Locked LIFESCI CAPITAL: Locked ➜ Locked	Oct 07 2024
Locked BTIG: Locked ➜ Locked	Oct 02 2024
Locked ODDO BHF: Locked ➜ Locked	Sep 09 2024

Discover more stocks with a high price target

Novo Nordisk 75.12%

Coinbase Global, Inc. 71.30%

BioNTech SE - ADR 48.29%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now